Recursion to Participate in Upcoming Investor Conference
SALT LAKE CITY, Feb. 1, 2023 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced…
SALT LAKE CITY, Feb. 1, 2023 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced…